comparemela.com
  1. Home
  2. Live Updates
  3. Sun Pharmaceutical Industries Limited - Breaking News

Latest Breaking News On - Sun pharmaceutical industries limited - Page 24 : comparemela.com

Global Glioblastoma Multiforme (GBM) Treatment Market Report 2023: Increasing Prevalence of Brain Disorders is Expected to Propel Growth

/PRNewswire/ The "Glioblastoma Multiforme (GBM) Treatment Global Market Report 2023" report has been added to ResearchAndMarkets.com s offering. This report.

United kingdomUnited statesSouth koreaLaura woodUniversity of tokyoJazz pharmaceuticals incTeva pharmaceutical industries ltdSun pharmaceutical industriesSurgical centersDaiichi sankyo companyGenentech incAmerican cancer societyVarian medical systemsInstitute of medical scienceCantex pharmaceuticals incEckert ziegler group

Sun Pharmaceutical Industries Ltd - Deuruxolitinib - CTP-543 - Clinical Program Update

Sun Pharmaceutical Industries Ltd has announced update on Deuruxolitinib - CTP-543 - Clinical Program.

Clinical programSun pharmaceutical industries ltdSun pharmaceutical industriesSerious adverse eventsOpen label extensionAlopecia areataBreakthrough therapyFast trackSun pharmaceutical industries limited

Sun Pharma launches therapy for Dry Eye Disease in India

CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology.

Kirti ganorkarSun pharmaRohit shettyNarayana nethralaya eye instituteSun pharmaceutical industries limited onSun pharmaceutical industries limitedDry eye diseaseIndia businessVice chairmanEye diseaseVisual display terminal

Sun Pharma launches CEQUA®, a novel therapy for Dry Eye Disease in India

Sun Pharmaceutical Industries Ltd has launched a novel ophthalmology treatment, CEQUA®, in India for patients who have Dry Eye Disease with inflammation, a commonly occurring condition.

Rohit shettyKirti ganorkarSun pharmaSun pharmaceutical industries limited reutersSun pharmaceutical industriesNarayana nethralaya eye instituteDry eye diseasePharmaceutical industries limitedVice chairmanEye diseaseVisual display terminalSun pharmaceutical industries limited

Sun Pharmaceutical Industries Limited updates on Mohali facility

US FDA has directed the Company to take certain corrective actions at the Mohali facility before releasing further final product batches into the US.

Madhya pradeshSun pharmaceutical industries limited mohali punjabSun pharmaceutical industriesSun pharmaceutical industries limited

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.